AdvaMed Ethics Compliance Survey Suggests More Analysis May Be Needed
Device manufacturers typically lack ways to measure the effectiveness of compliance training programs and industry ethics codes, though most firms use those tools to guard against misconduct, according to an AdvaMed-commissioned survey
More from Archive
More from Medtech Insight
Dxcover sets up new Clinical Laboratory Improvement Amendments (CLIA) lab in Franklin, Tennessee.
EnsoData positions itself as device-agnostic and interoperable, with FDA-cleared software that can integrate with all major devices. CEO Mortara said this flexibility helps maximize patient reach by enabling both direct provider engagement and integration with device manufacturers.
After multiple warning letters and safety communications, the US FDA has decided to block the import of certain endoscopes from Olympus. In total, the agency’s action pertains to 58 device models manufactured by the Japanese firm used in urinary, respiratory, abdominal and pelvic procedures.